Listing Category
Description
A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY STUDY OF TRONTINEMAB IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE(MCI TO MILD DEMENTIA DUE TO AD)